Literature DB >> 21913020

Salvage treatment for isolated regional failure of nasopharyngeal carcinoma after primary radiotherapy.

Wu-Chia Lo1, Cheng-Ping Wang, Jeng-Yuh Ko, Pei-Jen Lou, Tsung-Lin Yang, Chun-Wei Wang, Ya-Ling Hu, Tseng-Cheng Chen.   

Abstract

BACKGROUND: Isolated regional failure of nasopharyngeal carcinoma (NPC) after primary treatment is traditionally treated with radical neck dissection (RND). The roles of modified radical neck dissection (MRND) and postoperative radiotherapy after salvage surgery currently remain unclear.
METHODS: Medical records from our facility of all NPC patients with isolated regional failure after complete primary radiotherapy and receipt of radical surgery as a part of salvage treatment between January 1985 and December 2004 were retrospectively reviewed.
RESULTS: Forty-five patients were enrolled onto the study. On univariate analyses, the 5-year regional-free, disease-free, and overall survival rates were 67.7%, 47.8%, and 65.7% for patients who underwent salvage surgery alone and were 66.0%, 34.7%, and 61.3% for patients who received salvage surgery plus postoperative radiotherapy (P = 0.74, P = 0.39 and P = 0.7, respectively). The 5-year regional-free, disease-free, and overall survival rates were 87.4%, 53.5%, and 87.1% for patients undergoing RND and were 54.3%, 34.2%, and 50.5% for patients undergoing MRND (P = 0.01, P = 0.02 and P = 0.05, respectively). On multivariate analyses, recurrent N3 disease was the only adverse prognostic factor for disease-free and overall survival (P = 0.05 and P = 0.03, respectively).
CONCLUSIONS: RND or MRND alone may be the superior treatment for NPC patients with isolated regional failure after primary radiotherapy. Compared to MRND, radical neck dissection could provide better regional control. Postoperative radiotherapy seems to have no benefit on disease-free or overall survival. Distant metastasis is the major cause of death in these patients.

Entities:  

Mesh:

Year:  2011        PMID: 21913020     DOI: 10.1245/s10434-011-2018-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  3 in total

1.  The immunologic advantage of recurrent nasopharyngeal carcinoma from the viewpoint of Galectin-9/Tim-3-related changes in the tumour microenvironment.

Authors:  Tseng-Cheng Chen; Chao-Hsien Chen; Cheng-Ping Wang; Pei-Hsuan Lin; Tsung-Lin Yang; Pei-Jen Lou; Jenq-Yuh Ko; Chen-Tu Wu; Yih-Leong Chang
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

Review 2.  Emerging treatment options for nasopharyngeal carcinoma.

Authors:  Lu Zhang; Qiu-Yan Chen; Huai Liu; Lin-Quan Tang; Hai-Qiang Mai
Journal:  Drug Des Devel Ther       Date:  2013-02-01       Impact factor: 4.162

3.  Establishment of a prognostic scoring model for regional recurrent nasopharyngeal carcinoma after neck dissection.

Authors:  Xiaoyun Li; Chao Lin; Jinjie Yan; Qiuyan Chen; Xuesong Sun; Sailan Liu; Shanshan Guo; Liting Liu; Haojun Xie; Qingnan Tang; Yujing Liang; Ling Guo; Hao Li; Xuekui Liu; Xiang Guo; Linquan Tang; Haiqiang Mai
Journal:  Cancer Biol Med       Date:  2020-02-15       Impact factor: 4.248

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.